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Abstract Internalization of receptors and other cell surface
components is well known to occur via clathrin-mediated
endocytosis, although other less well characterized pathways
are also involved. Internalized receptors are then delivered to
early endosomes, where they are sorted to be recycled back to the
plasma membrane for reutilization or transported to late
endosomes/lysosomes for degradation. Endocytosis has long
been considered as a constitutive, housekeeping function of
animal cells that occurs independently of the cellular environment
in contrast to regulated secretion. Here, we will discuss recent
studies that are uncovering the existence of cross-talk between
signaling molecules and components of the transport machinery,
indicating that endocytosis can be modulated by signaling
pathways. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
By far the best characterized route of internalization into
animal cells is the clathrin-dependent pathway, which medi-
ates delivery of endocytosed cell surface components and sol-
utes to early endosomes. Then, molecules that need to be
reutilized, including receptors with housekeeping functions,
are recycled back to the plasma membrane. In contrast, mol-
ecules that need to be degraded, like downregulated growth
factor and hormone receptors, are transported to late endo-
somes and lysosomes. It has long been appreciated that ligand
binding controls the internalization and subsequent tra⁄cking
of downregulated receptors [1], and signaling may itself be
regulated by receptor tra⁄cking [2]. During downregulation,
the notion that prevails is that the number of transport
vesicles is not changed, but that ligand binding triggers incor-
poration of receptors into pits that form constitutively at the
plasma membrane. Recent studies, however, indicate that
Nef-mediated downregulation of cell surface CD4 molecules
occurs via a selective population of clathrin-coated vesicles [3].
In fact, it is becoming apparent that internalization pathways
can be tuned by signaling cascades. In addition, the function
of a number of molecules involved in tra⁄cking appears to be
regulated by post-translational modi¢cations (mainly phos-
phorylation). A complex network of protein^protein interac-
tions is also being revealed at the interface between signal
transduction and endocytic tra⁄c, supporting the notion
that tra⁄cking and signaling are integrated at the mechanistic
level. Finally, clathrin-independent routes of entry also exist,
and these can be modulated, at least in part, by signaling
cascades. In this review, we will focus on the cross-talk be-
tween signaling cascades and endocytic tra⁄c along clathrin-
dependent and -independent pathways (Fig. 1).
2. Clathrin-independent endocytic pathways
Evidence is accumulating that internalization can occur via
pathways that do not depend on clathrin [4]. Inhibition of the
clathrin pathway rapidly stimulates other internalization
routes, perhaps as a compensatory mechanism [5^7]. How-
ever, some components may be shared by clathrin-dependent
and -independent internalization pathways, including dyna-
min and synaptophysin [8,9]. Another dynamin- and clath-
rin-independent pathway may also exist [10]. One possible
route of entry involves cell surface microdomains containing
glycosphingolipids and cholesterol (rafts), which are believed
to play an important role in signaling and have a capacity for
internalization [11^13]. In fact, recent studies reveal that the
interleukin 2 receptor, in contrast to most known receptors
that are endocytosed via the clathrin pathway, is internalized
via a clathrin-independent route that may involve these micro-
domains [14]. Rafts can form pear-shaped invaginations
termed caveolae, when associated with caveolin [15], and these
seem to mediate endocytosis in endothelial cells, and perhaps
in other cell types [8,16].
Macropinocytosis is a non-clathrin route of entry related to
phagocytosis and associated with areas where membrane
spreading and ru¥ing take place. This route is modulated
and used by some pathogenic bacteria [17^19]. Macropinocy-
tosis is stimulated by the growth factor EGF [20] and by Ras
[21], the downstream regulator of the mitogenic response, but
presumably not in itself by endocytosis of occupied EGF re-
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ceptors [22]. Vesicles formed when membrane ru¥es, presum-
ably macropinosomes, move at the tips of actin tails [23], and
macropinocytosis, much like phagocytosis, involves remodel-
ing of the actin cytoskeleton. This process depends on coronin
in Dictyostelium and perhaps in mammalian cells [24], and on
signal transduction pathways involving Rho GTPases (Rho,
Rac and Cdc42) [25]. Rho GTPases also appear to be in-
volved in macropinocytosis downregulation during dendritic
cell maturation [26]. Both activated RhoA and Rac stimulate
pinocytosis, but inhibit clathrin-dependent endocytosis
[27,28]. Recent studies also indicate that the p21-activated
kinase PAK1, a target for activated Rac and Cdc42 regulating
the actin cytoskeleton, is also involved selectively in macro-
pinocytosis [29]. Constitutive ru¥ing and macropinocytosis in
oncogene-transformed ¢broblasts appear to depend on activa-
tion of both phosphatidylinositol-3-kinase (PI3K) and phos-
phatidylinositol (PI)-phospholipase C, leading to a reorgan-
ization of the actin cytoskeleton [30], in agreement with
previous studies indicating that PI3K is involved in macro-
pinocytosis [31].
3. Actin and signaling in endocytosis
It is becoming clear that the actin cytoskeleton plays a
general role in endocytosis, in addition to macropinocytosis
[28,32], but its precise role remains unclear. Signaling-depen-
dent reorganization of the actin cytoskeleton may contribute
to the spatial or temporal regulation of tra⁄cking routes [33].
Although the precise role of the small GTPase ARF6 is still
unclear, evidence suggests that it plays a role in some recy-
cling step as well as in cell spreading and adhesion [34,35],
maybe via its putative downstream e¡ector phosphatidylino-
sitol-4-phosphate 5-kinase involved in membrane ru¥ing [36].
As mentioned above, RhoA and Rac seem to be involved in
clathrin-dependent endocytosis, perhaps via interactions with
synaptojanin 2 in the case of Rac [37]. In addition, RhoD
regulates early endosome dynamic, perhaps by coordinating
interactions with the cytoskeleton [38]. Similarly, RhoB is
present on multivesicular bodies (MVBs) [39] and is involved
in EGF receptor downregulation [40], suggestive of a signal-
ing^tra⁄cking cross-talk [28]. In yeast, it was recently shown
that a lipid signaling pathway (based on sphingosine base
synthesis) regulates a protein phosphorylation cascade re-
quired for internalization [41,42]. A potential target for this
regulation pathway is the actin cytoskeleton, which plays an
important role in yeast endocytosis. Whether mammalian cells
also employ such a signaling pathway remains to be eluci-
dated.
Evidence is now compelling that phosphoinositides are in-
volved in the regulation of intracellular tra⁄cking in addition
to their role as second messenger, and these functions have
previously been reviewed in detail [43^45]. These signaling
lipids are now also implicated in receptor internalization
and tra⁄cking, and some directly bind components of the
clathrin coat [46,47]. Since phosphoinositides are involved in
signaling, tra⁄cking and actin cytoskeleton remodeling, they
obviously function as key regulators at the interface between
these major cellular processes [32,46].
4. Clathrin-mediated endocytosis
Many proteins involved in the clathrin-mediated internal-
ization process have now been characterized, including at the
atomic level [48,49]. It is becoming clear that endocytosis is
intimately coupled to signaling events at the cell surface via
di¡erent networks of protein^protein interactions and post-
translational modi¢cations [50]. This presumably re£ects the
need for tight regulatory mechanisms between interactions
occurring with the extracellular milieu and receptor tra⁄ck-
ing.
In PC12 cells, activation of TrkA by the neurotrophin NGF
was reported to increase clathrin-coated membrane formation
and clathrin-mediated membrane tra⁄cking [51]. In addition,
recent studies showed that EGF binding to its receptor causes
rapid phosphorylation of the clathrin heavy chain in a domain
controlling clathrin assembly, via downstream activation of
SRC kinase, indicating that receptor signaling contributes to
regulate endocytosis via SRC [52]. EGF receptor endocytosis
itself appears to depend on phospholipase D (PLD) [53], and
PLD activity could be inhibited by accessory proteins of the
brain clathrin coat, synaptojanin, AP180 and amphiphysin
[54]. Below, we will brie£y discuss individual components of
the clathrin coat and accessory proteins.
The role of dynamin as a GTPase that plays an essential
role in clathrin-coated vesicle formation is well documented
[55,56], although its precise function is still debated [57].
Members of the dynamin family may also function on intra-
cellular compartments [58], in addition to the caveolar path-
way in endothelial cells [8], and perhaps phagocytosis [59].
Dynamin can interact with amphiphysin (see below) and syn-
dapins, proteins which link endocytosis with the actin cyto-
Fig. 1. The pathways of endocytic tra⁄c are outlined on the ¢gure.
Internalization occurs via clathrin-coated pits and vesicles (CCP)
and via other pathways, including clathrin-independent invagina-
tions (CII) and macropinosomes (MP). Molecules internalized via
the clathrin pathway, and perhaps also via other pathways, then ap-
pear in early endosomes (EE). From there, some components are re-
cycled back to the plasma membrane (PM), directly from EE or in-
directly via recycling endosomes (RE). Molecules destined to be
degraded are collected within transport intermediates (MVBs or
ECVs) and then are transported to late endosomes (LE) and lyso-
somes (LYS) for degradation. Lightning arrows point at tra⁄cking
steps believed to be regulated by signaling cascades.
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skeleton [32]. Recent studies suggest that dynamin-2 may act
as a signal-transducing GTPase, since its overexpression acti-
vates the transcription factor p53 and induces apoptosis [60].
Amphiphysin plays a key role in endocytosis by recruiting
dynamin to clathrin-coated pits [61^63]. Amphiphysin I is
found exclusively in brain and its phosphorylation inhibits
binding to clathrin and the AP2 adaptor complex. Phosphor-
ylation of dynamin and synaptojanin prevents binding to am-
phiphysin, indicating that phosphorylation regulates the cycle
of the clathrin machinery [64,65]. Association of amphiphysin
II with dynamin in PC12 cells was observed after stimulation
with NGF, suggesting that the protein contributes to connect
endocytosis and signal transduction pathways [66]. This dual
function of amphiphysin II is also apparent in its reported
ability to interact with the Ras exchange factor Sos in vitro
[66].
Synaptojanin is an accessory protein of the clathrin machi-
nery at the synapse. Clathrin-coated pits or vesicles accumu-
late at the nerve terminals of synaptojanin knock out mice
[67], and in mutants of the synaptojanin orthologue in Caeno-
rhabditis elegans (unc-26) [68]. The latter mutants also exhibit
cytoskeletal abnormalities, and synaptojanin 2, a novel ubiq-
uitously expressed isoform, was recently identi¢ed as a Rac1
e¡ector [37]. Synaptojanin is a polyphosphoinositide phospha-
tase that binds directly to both PI(4,5)P2 and proteins impli-
cated in clathrin-mediated endocytosis [69,70]. These include
amphiphysin, syndapins [71] and endophilin, a lysophospha-
tidic acid acyl transferase presumably involved in ¢ssion dur-
ing clathrin-mediated synaptic vesicle endocytosis [72,73].
Synaptojanin may also interact with Grb2, an adaptor in-
volved in mitogen-dependent signaling cascades [69].
Eps15 was originally identi¢ed as a substrate for the EGF
receptor kinase [74] and subsequently implicated in endocyto-
sis [75,76]. Eps15 and epsin are interacting partners for the K-
adaptin subunit of the AP2 adaptor complex and triggered
dephosphorylation increases binding to AP2 [77]. In addition,
Eps15 phosphorylation was recently shown to be required for
ligand-regulated, but not constitutive, endocytosis, suggesting
that di¡erent mechanisms regulate tra⁄cking of these recep-
tors [78]. Epsin 1 was also shown to undergo nucleocytosolic
shuttling and to interact with the transcription factor promye-
locytic leukemia (PLZF), suggesting that epsin may be part of
a signaling pathway involving endocytosis [79]. Intersectin, a
multiple EH and SH3 domain-containing protein, is yet an-
other protein that may link endocytosis with cell growth and
di¡erentiation [80,81]. It binds dynamin, Eps15 and epsin, and
intersectin mutants inhibit transferrin receptor endocytosis
[82,83]. Intersectin also appears to interact with the Ras ex-
change factor Sos, and overexpression of intersectin SH3 do-
main a¡ects EGF-mediated mitogen-activated protein kinase
(MAPK) activation through Ras [80].
5. The ¢rst endocytic station and the small GTPase Rab5
After internalization from most if not all entry routes, cell
surface molecules, including receptors, are delivered to periph-
eral early endosomes. The small GTPase Rab5 is one of the
key regulators of this early endocytic tra⁄c, and it has been
proposed that Rab5 functions as an organizer of early endo-
somal membranes via interactions with its e¡ectors [84]. Evi-
dence is now accumulating that signaling and Rab5-depen-
dent pathways intersect in tra⁄cking regulation.
Rab5, like Ras and other GTPases, cycles between GTP-
and GDP-bound form, and GTP hydrolysis depends on a
GTPase-activating protein (GAP). Several Rab5 GAPs have
been identi¢ed. Some evidence, in fact, suggests that the cata-
lytic domain of p120GAP, which acts on Ras and thereby
regulates the EGF-dependent mitogenic response [85], inter-
acts physically with Rab5 and stimulates its GTPase activity
[86]. EGF stimulation was also reported to activate Rab5
functions, consistent with the notion that a relationship exists
between receptor activation and internalization [87,88]. An-
other recently identi¢ed Rab5GAP, RN-tre, is regulated by
the EGF receptor [89]. Interestingly, the Eps8 substrate of
the EGF receptor seems to interact either with RN-tre in
tra⁄cking or with E3bl in signaling through Rac. It has
also been proposed that PKB/akt, a protein kinase involved
in insulin and PDGF signaling, mediates the stimulatory e¡ect
of Ras on endocytosis via Rab5 [90].
In addition to cycling between GTP- and GDP-bound
states, Rab5, like other Rabs, cycles between the membrane
and cytosol [84,91]. This latter cycle depends on GDI, which
functions as a Rab vehicle in the aqueous environment of the
cytosol. GDI is present in several isoforms, but clear func-
tional di¡erences have not been found amongst isoforms.
Phosphorylation of GDI-2 on Tyr residues triggered by insu-
lin stimulation of adipocytes enhances the selective extraction
of the small GTPase Rab4, which is involved in receptor
recycling to the cell surface [92^94]. Similarly, GDI-K is phos-
phorylated on Ser residues in vivo [95,96]. Recently we found
that the MAPK p38 regulates the activity of GDI in the
cytosolic cycle of Rab5, and that GDI Ser121 is essential in
this process [97]. Selective activation of p38 MAPK increases
endocytic rates in vivo, presumably allowing more e⁄cient
internalization of cell surface components for repair, storage,
or degradation [97]. These observations emphasize the pos-
sibility that stress stimuli may contribute to the regula-
tion of endocytosis and perhaps other pathways via p38 and
GDI.
6. FYVE proteins
The early endosomal protein EEA1 [98] is also an e¡ector
of Rab5 essential for endosome fusion, and is recruited to
endosomal membranes via binding not only to Rab5:GTP,
but also to phosphatidylinositol-3-phosphate (PI(3)P) via a
zinc ¢nger referred to as FYVE domain [99^103]. These ob-
servations have led to the identi¢cation of a family of proteins
bearing the consensus PI(3)P binding FYVE motif [104,105],
and structural information has recently been obtained on
PI(3)P^FYVE interactions [106,107]. Since PI(3)P may be
present primarily at early steps of the endocytic pathway
[108], one may wonder whether all FYVE proteins are pref-
erentially targeted to these membranes.
The FYVE protein Hrs (hepatocyte growth factor-regulated
tyrosine kinase substrate) localizes to early endosomes. Inter-
actions with PI(3)P are required for localization and phos-
phorylation in response to EGF stimulation [109^111], but
the role of the FYVE ¢nger in localization is not clear
[112]. Hrs is the homologue of the class E vps gene product
Vps27p in yeast, a protein known to be required for vesicular
tra⁄cking [113]. Hrs was also found associated with STAM
(signal-transducing adaptor molecule), perhaps counteracting
STAM functions in cell growth signaling [114]. Targeted dis-
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ruption of the Hrs gene in mice is embryonically lethal and
the enlarged endosomes observed indicated that Hrs and en-
dosomal function are required for ventral morphogenesis
[111]. SARA (Smad anchor for receptor activation) is another
FYVE protein that is presumably involved in TGFL signaling,
by interacting with Smads, which transmit signals from Ser/
Thr kinase receptors to the nucleus [115].
Fab1p is a yeast protein essential for the maintenance of
normal vacuolar morphology in yeast that contains an N-ter-
minal FYVE domain, but also exhibits PI(3)P-5-OH kinase
activity and thus converts PI(3)P into phosphatidylinositol-
3,5-bisphosphate (PI(3,5)P2) [105,116,117]. Fab1p was pro-
posed to regulate vacuole membrane homeostasis, and per-
haps anterograde transport to the vacuole [117], but also car-
go-selective sorting into the vacuole lumen ([118] and see
below). Interestingly, PI(3,5)P2 was only recently discovered
in mammalian cells, and is produced in response to osmotic
stress [119,120]. PIKfyve, the putative human orthologue of
Fab1p, contains an N-terminal FYVE domain and is localized
to a peripheral punctate pattern [121,122], but its precise func-
tion has not been determined yet.
7. The recycling circuit
Once delivered to early endosomes, constitutively recycling
receptors like the transferrin receptor are returned to the cell
surface, at least in part via recycling endosomes, in contrast to
downregulated receptors, which are transported to late endo-
somes and lysosomes [123]. Oxidative stress, which activates
p38 MAPK, causes a rapid and speci¢c redistribution of
transferrin receptor from the cell surface to intracellular mem-
branes, possibly recycling endosomes, presumably by interfer-
ing with receptor recycling [124,125]. Whether this mechanism
depends on Rab GTPases involved in recycling via GDI phos-
phorylation by p38 MAPK [97] remains to be investigated.
Rab11 is believed to regulate transport along this pathway
[126]. Recent studies have identi¢ed Rip11 as a novel Rab11
e¡ector in epithelial cells involved in apical membrane traf-
¢cking via recycling endosomes, and its membrane association
appears to be regulated by phosphorylation [127].
The small GTPase Rab4 is also involved in the recycling
pathway [92], perhaps at a step earlier than Rab11 [128]. Rab4
was proposed to regulate the insulin-dependent transporter
GLUT-4 [129,130]. Conversely, insulin was shown to promote
phosphorylation and activation of geranyl-geranyltransferase
II in both 3T3 ¢broblasts and adipocytes, resulting in in-
creased amounts of geranyl-geranylated Rab3 and Rab4
[131]. Insulin was also shown to mediate the activation of
farnesyl transferase and to increase the farnesylation of Ras,
and the process was sensitive to MAPK inhibitors [132^134].
Similarly, Rab4 itself was reported to be phosphorylated by
the insulin-activated extracellular signal-regulated kinase
ERK1 [135], further involving the MAPK pathways in the
control of membrane tra⁄cking.
8. The pathway from early to late endosomes
In contrast to recycling receptors, some endocytosed pro-
teins, including downregulated receptors, are e⁄ciently trans-
ported from early to late endosomes [123]. While there is no
doubt that sorting occurs at this step, little is known about the
signals that may be involved. In mammalian cells, precise se-
quence motifs have only been identi¢ed in interleukin 2 re-
ceptor L-chain [136,137], p-selectin [138], and HIV Nef during
CD4 downregulation [139]. Recent studies also point at the
possible role of receptor ubiquitination in sorting at this step
[140]. However, it is also becoming apparent that sorting in
early endosomes may be lipid-based along both recycling and
degradation pathways [46,141,142]. Indeed, lipids do not ap-
pear to be stochastically incorporated into either pathway,
and they might thus contribute to sorting by facilitating pref-
erential protein partitioning into de¢ned lipidic environments.
Transport from early to late endosomes is mediated by inter-
mediates with a characteristic multivesicular appearance, re-
ferred to as MVBs or endosomal carrier vesicles (ECVs) [123],
and their biogenesis is dependent on endosomal COPs and
ARF1 in mammalian cells [143,144].
In yeast, evidence is accumulating that phosphoinositide
signaling, via PI3K and PI(3)P, plays a critical role in MVB
function [44]. In fact, PI(3,5)P2 synthesis via the PI(3)P-5-OH
kinase Fab1p is believed to be coupled to the regulation of
MVB sorting [118]. Although the functional relationships be-
tween yeast and mammalian MVBs are still not completely
clear, it has been reported that wortmannin, a drug that in-
hibits PI3K, inhibits MVB formation in animal cells [145].
PI(3)P was also found within internal membrane of ECV/
MVBs but not of late endosomes [108]. Whether these signal-
ing lipids promote membrane invagination remains to be
clearly established. The yeast class E vps mutants all appear
to interfere with MVB biogenesis [44,140]. Several other class
E mutants have a mammalian homologue, Vps31p/alix,
Vps23p/tsg101 and the recently identi¢ed vps4/SKD1. tsg101
is a tumor susceptibility gene 101 and its disruption induces
cell transformation [146]. It was also proposed that tsg101
regulates lysosomal degradation of cell surface components
including mitogenic receptors, perhaps contributing to the tu-
morigenic phenotype of the mutants [147,148].
In mammalian cells, ECV/MVBs, once formed on early
endosomes, move towards late endosome on microtubules
and then dock onto and fuse with late endosomes [123]. Little
is known about the possible cross-talk between late endo-
somes/lysosomes and signaling pathways. However, recent
studies identi¢ed a novel 14 kDa protein that interacts with
the MAPK sca¡old protein MP1 (MEK partner 1), on late
endosomes/lysosomes [149], but its function on these mem-
branes is unclear. In addition, major membrane remodeling
occurs within late endosomes. Their invaginations selectively
accumulate large amounts of the unusual phospholipid lyso-
bisphosphatidic acid, which is involved in cholesterol and
protein tra⁄cking [150,151]. Both cholesterol and sphingolip-
ids accumulate within late endosomes and within lysosomes in
some lipid storage diseases, which may lead to signaling de-
fects, since these raft lipids are presumably involved in signal
transduction processes [152]. In addition, Rab prenylation and
cholesterol synthesis use the same isoprene precursor. Hence
diseases that a¡ect cholesterol synthesis or storage may well
a¡ect Rab functions.
9. Conclusions and perspectives
Major progress has been made in unraveling the complex
network of interactions between di¡erent signaling pathways
and regulation of endocytic tra⁄c. However, it is also clear
that much work is still needed to dissect these networks at the
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mechanistic level, including in development and in di¡erent
tissues, and to characterize the precise role of each compo-
nent. Signaling cascades appear to control not only internal-
ization steps, but also the fate of internalized molecules along
recycling and degradation pathways, by modulating tra⁄ck-
ing routes. It is attractive to speculate that extracellular stim-
uli contribute to the endocytosis of cell surface components
for repair, storage or degradation. In addition, tra⁄c regula-
tion by external stimuli emphasizes the possible role of this
cross-talk in infection, aging and a number of degenerative
diseases. Much e¡ort has been invested in understanding the
basic machineries regulating membrane tra⁄c over the past
decade. These have opened new research avenues which aim
at a better understanding of the tuning mechanisms in mem-
brane tra⁄c.
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